title: Effect of oestradiol on ovarian oxytocin secretion rate and luteolysis in the ewe after ovarian auto-transplantation.
abstract: The release of ovarian oxytocin and uterine prostaglandin (PG)F2alpha in response to an oestradiol stimulus was investigated. On Day 15 post-oestrus, ten ewes with ovarian auto-transplants (n=5 per group) received an intra-muscular injection of either oestradiol benzoate (50 microg) or vehicle. Blood samples were collected from the ovarian and jugular veins at 30 and 0 min before, and at 15-min intervals up to 540 min after, injection. The secretion rate of ovarian progesterone remained elevated in four of five treated ewes and in all control ewes, indicating the presence of a functional corpus luteum. Peripheral oestradiol concentrations were significantly (P < 0.001) higher in treated than in control ewes. The number of ewes that released pulses of ovarian oxytocin > or =240 min following oestradiol benzoate injection was significantly (P < 0 05) greater than that in control ewes. Mean amplitude and area under both ovarian-vein oxytocin and jugular-vein 15 keto-13,14 dihydro prostaglandin F2alpha (PGFM) pulses were significantly increased in the treated ewes. These findings demonstrate that the administration of exogenous oestrogen provides a positive stimulus for the release of ovarian oxytocin and uterine PGF2alpha in the ovarian auto-transplanted ewe.
authors.affiliation: Centre for Bioprocessing and Food Technology, Victoria University of Technology, Melbourne, Australia. s9410312@cougar.vut.edu.au
authors.forename: H Y
authors.initials: HY
authors.lastname: Al-Matubsi
authors.forename: J
authors.initials: J
authors.lastname: Downing
authors.forename: G
authors.initials: G
authors.lastname: Jenkin
authors.forename: R J
authors.initials: RJ
authors.lastname: Fairclough
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology; D015237:Dinoprost / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D004971:Estrus / Q000502:physiology; D005260:Female; D007273:Injections, Intramuscular; D007700:Kinetics; D010053:Ovary / Q000187:drug effects / Q000378:metabolism* / Q000637:transplantation*; D010121:Oxytocin / Q000378:metabolism*; D012756:Sheep / Q000502:physiology*; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
chemical_list: C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D004958:Estradiol; D010121:Oxytocin; D015237:Dinoprost